DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

xvi
CONTRIBUTORS
Robert H. Tukey, PhD
Professor of Pharmacology and Chemistry/Biochemistry
University of California, San Diego
Flavio Vincenti, MD
Professor of Clinical Medicine
Medical Director, Pancreas Transplant Program
University of California, San Francisco
Joseph M. Vinetz, MD
Professor of Medicine, Division of Infectious Diseases
University of California, San Diego
Mark S. Wallace, MD
Professor of Clinical Anesthesiology
University of California, San Diego
John L. Wallace, PhD, MBA, FRSC
Professor and Director, Farncombe Family Digestive Health
Research Institute
McMaster University, Hamilton, Ontario
Jeffrey I. Weitz, MD, FRCP(C), FACP
Professor of Medicine, Biochemistry and Biomedical Sciences
McMaster University
Executive Director, Thrombosis & Atherosclerosis
Research Institute, Hamilton, Ontario
David P. Westfall, PhD
Professor (Emeritus) of Pharmacology
University of Nevada School of Medicine, Reno
Thomas C. Westfall, PhD
Professor and Chair of Pharmacological and Physiological
Science
St. Louis University School of Medicine, Missouri
Wyndham Wilson, MD, PhD
Senior Investigator and Chief of Lymphoid Therapeutics
Section,
Center for Cancer Research, National Cancer Institute
Bethesda Maryland
Tony L. Yaksh, PhD
Professor of Anesthesiology and Pharmacology
University of California, San Diego
Alexander C. Zambon, PhD
Assistant Professor of Pharmacology
University of California, San Diego